12900 Results (Page 27 of 516)
All Market Research Reports
Egypt Clinical Nutrition for Diabetes Care Market Analysis
The Egypt Clinical Nutrition for Diabetes Care Market was valued at $6.02 Mn in 2023 and is predicted to grow at a CAGR of 6.28% from 2023 to 2030, to $9.22 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Sanofi, Pharco Pharmaceuticals, and Novo Nordisk among others.
Vietnam Clinical Nutrition for Diabetes Care Market Analysis
The Vietnam Clinical Nutrition for Diabetes Care Market was valued at $10.75 Mn in 2023 and is predicted to grow at a CAGR of 5.01% from 2023 to 2030, to $15.14 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Roche Diabetes Care, Sanofi and Novo Nordisk among others.
Singapore Clinical Nutrition for Diabetes Care Market Analysis
The Singapore Clinical Nutrition for Diabetes Care Market was valued at $2.58 Mn in 2023 and is predicted to grow at a CAGR of 5.38% from 2023 to 2030, to $3.72 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Nutribio, Pfizer Inc., and Novo Nordisk among others.
Philippines Clinical Nutrition for Diabetes Care Market Analysis
The Philippines Clinical Nutrition for Diabetes Care Market was valued at $4.73 Mn in 2023 and is predicted to grow at a CAGR of 5.28% from 2023 to 2030, to $6.78 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are United Laboratories, Inc. (Unilab), Zuellig Pharma, Sanofi, and Novo Nordisk among others.
Malaysia Clinical Nutrition for Diabetes Care Market Analysis
The Malaysia Clinical Nutrition for Diabetes Care Market was valued at $3.46 Mn in 2023 and is predicted to grow at a CAGR of 4.98% from 2023 to 2030, to $4.86 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, B.Braun, Novo Nordisk, and Perrigo Company among others.
Japan Clinical Nutrition for Diabetes Care Market Analysis
The Japan Clinical Nutrition for Diabetes Care Market was valued at $133.64 Mn in 2023 and is predicted to grow at a CAGR of 5.28% from 2023 to 2030, to $191.58 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Eli Lily, Danone, AgaMatrix Inc., and among others.
Indonesia Clinical Nutrition for Diabetes Care Market Analysis
The Indonesia Clinical Nutrition for Diabetes Care Market was valued at $12.90 Mn in 2023 and is predicted to grow at a CAGR of 4.78% from 2023 to 2030, to $17.89 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Danone SA, Perrigo Company, and Abbott Nutrition among others.
China Clinical Nutrition for Diabetes Care Market Analysis
The China Clinical Nutrition for Diabetes Care Market was valued at $172.83 Mn in 2023 and is predicted to grow at a CAGR of 6.28% from 2023 to 2030, to $264.72 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nutreco, Sanofi SA, Danone Nutricia, and Abbott Nutrition among others.
UK Clinical Nutrition for Diabetes Care Market Analysis
The UK Clinical Nutrition for Diabetes Care Market was valued at $55.90 Mn in 2023 and is predicted to grow at a CAGR of 2.78% from 2023 to 2030, to $67.73 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Nualtra, Clinova Ltd, and Novo Nordisk among others.
Spain Clinical Nutrition for Diabetes Care Market Analysis
The Spain Clinical Nutrition for Diabetes Care Market was valued at $41.50 Mn in 2023 and is predicted to grow at a CAGR of 3.78% from 2023 to 2030, to $53.80 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Mediquo, Sweetcare, Pfizer Inc., and Mefood Omics among others.
Germany Clinical Nutrition for Diabetes Care Market Analysis
The Germany Clinical Nutrition for Diabetes Care Market was valued at $78.69 Mn in 2023 and is predicted to grow at a CAGR of 2.98% from 2023 to 2030, to $96.65 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Fresenius Kabi, Baxter International, and Novo Nordisk among others.
France Clinical Nutrition for Diabetes Care Market Analysis
The France Clinical Nutrition for Diabetes Care Market was valued at $59.13 Mn in 2023 and is predicted to grow at a CAGR of 3.78% from 2023 to 2030, to $76.66 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Nutribio, Sanofi S.A., and Baxter International Inc. among others.
Saudi Arabia Exosome Research Market Analysis
The Saudi Arabia Exosome Research Market was valued at $1.1 Mn in 2023 and is projected to grow at a CAGR of 17.23% from 2023 to 2023, to $3.3 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Hologic Inc., Luminex Corporation, QIAGEN, Agilent Technologies among others.
Brazil Clinical Nutrition for Diabetes Care Market Analysis
The Brazil Clinical Nutrition for Diabetes Care Market was valued at $53.75 Mn in 2023 and is predicted to grow at a CAGR of 5.78% from 2023 to 2030, to $79.65 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Nutribio, Pfizer Inc., and Novo Nordisk among others.
UAE Clinical Nutrition for Diabetes Care Market Analysis
The UAE Clinical Nutrition for Diabetes Care Market was valued at $10.75 Mn in 2023 and is predicted to grow at a CAGR of 5.78% from 2023 to 2030, to $15.93 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestlé Health Science, Eli Lily, Baxter International, Boehringer Ingelheim, and among others.
Saudi Arabia Clinical Nutrition for Diabetes Care Market Analysis
The Saudi Arabia Clinical Nutrition for Diabetes Care Market was valued at $36.55 Mn in 2023 and is predicted to grow at a CAGR of 6.28% from 2023 to 2030, to $55.98 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Sanofi, Nestlé Health Science, Danone Nutricia, and Novo Nordisk among others.
US Clinical Nutrition for Diabetes Care Market Analysis
The US Clinical Nutrition for Diabetes Care Market was valued at $903 Mn in 2023 and is predicted to grow at a CAGR of 2.78% from 2023 to 2030, to $1094.08 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Perrigo Company PLC, Eli Lilly, and Baxter International Inc. among others.
Canada Clinical Nutrition for Diabetes Care Market Analysis
The Canada Clinical Nutrition for Diabetes Care Market was valued at $172 Mn in 2023 and is predicted to grow at a CAGR of 4.78% from 2023 to 2030, to $238.49 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Eli Lily, Danone, AgaMatrix Inc., and among others.
India Pharmacy Automation Device Market Analysis
The India Pharmacy Automation Device Market was valued at $100 Mn in 2023 and is predicted to grow at a CAGR of 12.9% from 2023 to 2030, to $233.9 Mn by 2030. India Pharmacy Automation Device Market is growing due to Increasing Healthcare Expenditure, Rising Chronic Disease Burden, Cost Containment and Efficiency. The market is primarily dominated by players such as Cotmac Electronics Pvt Ltd, Zifo Technologies, Becton Dickinson and Company, Omron Healthcare Co Ltd, Capsa Solutions, LLC, Pearson Medical Technologies LLC, Cotmac Electronics Pvt Ltd, Baxter; Talyst, LLC.
South Africa Pharmacy Automation Device Market Analysis
The South Africa Pharmacy Automation Device Market was valued at $35.8 Mn in 2023 and is predicted to grow at a CAGR of 11.13% from 2023 to 2030, to $74.8 Mn by 2030. South Africa Pharmacy Automation Device Market is growing due to Growing Need to Minimize Medication Errors, Increasing Healthcare Expenditure, and Advancing Technology. The market is primarily dominated by players such as Cerner Corporation, Capsa Healthcare, ScriptPro LLC, RxSafe, LLC., MedAvail Technologies, Amerisource Bergen Corporation, and Omnicell, Inc.
Kenya Pharmacy Automation Device Market Analysis
The Kenya Pharmacy Automation Device Market was valued at $3.9 Mn in 2023 and is predicted to grow at a CAGR of 11% from 2023 to 2030, to $8 Mn by 2030. Kenya Pharmacy Automation Device Market is growing due to Growing Need to Minimize Medication Errors, Rising Demand for Pharmaceuticals, Government Initiatives, and Investments. The market is primarily dominated by players such as Becton Dickinson and Co, Capsa Solutions LLC, Omnicell Inc, Oracle Corp, Veradigm LLC, Swisslog Healthcare AG, McKesson Corporation; and Pearson Medical Technologies.
Egypt Pharmacy Automation Device Market Analysis
The Egypt Pharmacy Automation Device Market was valued at $15.4 Mn in 2023 and is predicted to grow at a CAGR of 11.4% from 2023 to 2030, to $32.8 Mn by 2030. Egypt Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Growing Need to Minimize Medication Errors, Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Becton Dickinson and Co, Capsa Solutions LLC, Omnicell Inc, Oracle Corp, Veradigm LLC, Swisslog Healthcare AG, McKesson Corporation; Pearson Medical Technologies.
Vietnam Pharmacy Automation Device Market Analysis
The Vietnam Pharmacy Automation Device Market was valued at $27.5 Mn in 2023 and is predicted to grow at a CAGR of 10.13% from 2023 to 2030, to $54 Mn by 2030. Vietnam Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Growing Need to Minimize Medication Errors, Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Kawasaki Heavy Industries Ltd., Fanuc Corporation, Kuka Ag, Mitsubishi Electric Corporation, Becton Dickinson and Co, Capsa Solutions LLC, McKaesson Corporation; Pearson Medical Technologies.
Singapore Pharmacy Automation Device Market Analysis
The Singapore Pharmacy Automation Device Market was valued at $6.6 Mn in 2023 and is predicted to grow at a CAGR of 10.5% from 2023 to 2030, to $13.3 Mn by 2030. Singapore Pharmacy Automation Device Market is growing due to Demand for Efficiency, Rising Demand for Pharmaceuticals, and end-user adoption. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC.
Philippines Pharmacy Automation Device Market Analysis
The Philippines Pharmacy Automation Device Market was valued at $12.1 Mn in 2023 and is predicted to grow at a CAGR of 10.4% from 2023 to 2030, to $24.2 Mn by 2030. Philippines Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Growing Need to Minimize Medication Errors, Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Becton Dickinson and Co, Capsa Solutions LLC, Omnicell Inc, Oracle Corp, Veradigm LLC, Swisslog Healthcare AG, McKaesson Corporation; Pearson Medical Technologies, Baxter; Talyst.